A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome for Treatment of Invasive Aspergillosis (IA).
Latest Information Update: 17 Apr 2014
At a glance
- Drugs Anidulafungin (Primary) ; Amphotericin B
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer; Vicuron Pharmaceuticals
Most Recent Events
- 17 Apr 2014 New trial record